Searchable abstracts of presentations at key conferences in endocrinology

Endocrine Abstracts

Published by BioScientifica
Previous issue | Volume 35 | ECE2014 | Next issue

16th European Congress of Endocrinology

Poster Presentations

Bone and Osteoporosis

Previous section
Adrenal Medulla
Table of contents
Next section
Calcium and Vitamin D metabolism

ea0035p65 | Bone and Osteoporosis

Postpartum osteoporosis with acute evolution: case report

ea0035p66 | Bone and Osteoporosis

The investigation of the awareness of bone health in patients with postmenopauosal in the region of Northeastern Anatolia

ea0035p67 | Bone and Osteoporosis

Baseline characteristics of Greek patients enrolled in the ExFOS study

ea0035p68 | Bone and Osteoporosis

From EFOS to ExFOS: any news with teriparatide prescription habits in Greece?

ea0035p69 | Bone and Osteoporosis

Subclinical celiac disease presented with postpartum low-back pain: case report

ea0035p70 | Bone and Osteoporosis

Vitamin D receptor (VDR) gene polymorphisms and the risk of low bone mass in type 1 diabetic patients

ea0035p71 | Bone and Osteoporosis

Bone mineral density in Iranian patients: effects of age, sex, and BMI

ea0035p72 | Bone and Osteoporosis

Characteristics of the endocrine osteoporosis

ea0035p73 | Bone and Osteoporosis

Efficacy of zoledronic acid treatment in Paget disease of bone

ea0035p74 | Bone and Osteoporosis

The relationship between the existence and degree of coronary atherosclerosis with the level of parathormone

ea0035p75 | Bone and Osteoporosis

What factors influenced on femoral neck bone mineral density in postmenopausal women?

ea0035p76 | Bone and Osteoporosis

Serum concentration of pentosidine and adipocytokines is related to fragile bone fractures in patients with type 2 diabetes mellitus

ea0035p77 | Bone and Osteoporosis

A girl with a hard painful swelling at the right hip: hyperphosphatemic tumeral calcinosis

ea0035p78 | Bone and Osteoporosis

Does testosteron have an effect on bone mineral density in postmenopausal women?

ea0035p79 | Bone and Osteoporosis

Renal aspects of primary hyperparathyroidism

ea0035p80 | Bone and Osteoporosis

1,25-dihydroxyvitamin D3 decreases the proinflammatory interleukin 17 serum levels

ea0035p81 | Bone and Osteoporosis

Factors associated with vertebral fractures in patients with primary hyperparathyroidism

ea0035p82 | Bone and Osteoporosis

Structure of bone disease the different clinical forms of primary hyperparathyroidism

ea0035p83 | Bone and Osteoporosis

Low-carbohydrate/high-fat diets do not have negative effects on bone density in female rats in contrast to male rats

ea0035p84 | Bone and Osteoporosis

Teriparatide treatment in a patient with severe pregnancy related osteoporosis

ea0035p85 | Bone and Osteoporosis

The total fat mass and the fracture risk assessment: a study in 146 Romanian menopausal women

ea0035p86 | Bone and Osteoporosis

The 10-year absolute fracture risk and central DXA correlations in 505 Romanian menopausal women

ea0035p87 | Bone and Osteoporosis

Bone mineral density, bone turnover and vitamin D status in women with diabetes mellitus type 2 and healthy women with osteoporosis in menopause

ea0035p88 | Bone and Osteoporosis

The −857C/T single-nucleotide polymorphism of TNFα gene is associated with bone mineral density in Greek peri- and postmenopausal women

ea0035p89 | Bone and Osteoporosis

State of bone metabolism in patients with urolithiasis

ea0035p90 | Bone and Osteoporosis

Familial hypocalciuric hypercalcemia: an important differential diagnosis from hyperparathyroidism

ea0035p91 | Bone and Osteoporosis

Usefulness of serum sclerostin as a diagnostic marker of osteoporosis in a cohort of spanish postmenopausal women

ea0035p92 | Bone and Osteoporosis

Increased osteoporotic fractures' risk in elderly patients with lower sodium levels

ea0035p93 | Bone and Osteoporosis

The effects of recombinant human TSH on selected bone markers in the follow-up of patients treated for differentiated thyroid carcinoma

ea0035p94 | Bone and Osteoporosis

Influence of osteoporosis risk factors on extensive suppression of bone metabolism during antiresorptive therapy

ea0035p95 | Bone and Osteoporosis

Osteoporosis in young male secondary to cancer treatment: case report

ea0035p96 | Bone and Osteoporosis

Jaw osteonecrosis in a patient with postmenopausal osteoporosis on antiresorptive treatment

ea0035p97 | Bone and Osteoporosis

Assessment of OPG/RANK/RANKL gene expression levels in peripheral blood mononuclear cells after treatment with hormonal replacement therapy and tibolone in patients after menopause with osteopenia or postmenopausal osteoporosis

ea0035p98 | Bone and Osteoporosis

Assessment of OPG and RANKL serum levels after treatment with hormonal replacement therapy and tibolone in patients after menopause with osteopenia or postmenopausal osteoporosis

ea0035p99 | Bone and Osteoporosis

Effect of estroprogestagen treatment on bone mineral density and concentration of osteoprotegerin in girls with Turner syndrome

ea0035p100 | Bone and Osteoporosis

Bone mineral density in girls with functional hypothalamic amenorrhea subjected to estroprogestagen treatment: a 4-year prospective study

Published by BioScientifica

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more